About the Post-Conference Planner
- In total 27 abstracts were relevant to the RNA module, 5 of which were late-breaking. 9 new RNA assets were identified from the abstracts presented at 2022 AACR.
- This report provides an analysis of the 27 abstracts, assessed by delivery system, therapeutic class, and disease indication, followed by top-level summaries of the preclinical and clinical abstracts presented.
Find out more
Speak with our Team
Our dedicated teams are on hand to showcase how Beacon can help you find the answers to your RNA questions.
About Beacon Targeted Therapies
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
